What one share of Processa Pharmaceuticals holds
Processa Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$5.62 |
|---|---|
| Cash and investments | $0.07 |
| Book value | −$0.11 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$353.05 | — | — | — | $877.92 |
| 2019 | — | −$349.71 | — | — | — | $730.19 |
| 2020 | — | −$1,269 | — | — | — | $808.77 |
| 2021 | $0.00 | −$372.97 | — | — | — | $811.10 |
| 2022 | $0.00 | −$851.18 | — | — | — | $232.94 |
| 2023 | — | −$211.99 | $0.05 | −$153.75 | — | $96.99 |
| 2024 | — | −$96.78 | $0.03 | −$91.87 | — | $11.45 |
| 2025 | — | −$10.36 | — | — | — | $2.17 |
Common questions about Processa Pharmaceuticals
How much does one share of Processa Pharmaceuticals earn?
Over the last 12 months, Processa Pharmaceuticals lost $5.62 for each share.
Does Processa Pharmaceuticals pay a dividend?
Processa Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Processa Pharmaceuticals’s book value per share?
Processa Pharmaceuticals’s book value is negative (−$0.11 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Processa Pharmaceuticals have?
Each share of Processa Pharmaceuticals has $0.07 of cash and investments, as of June 30, 2026.
Has Processa Pharmaceuticals bought back shares?
Processa Pharmaceuticals’s share count rose about 12177% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.